Clinical trial · Observational
Impact of Blood Salvage Therapy on Outcomes After Oncologic Liver Surgery
Impact of Blood Salvage Therapy During Oncologic Liver Surgeries on Allogenic Transfusion Events, Survival and Recurrence
NCT05164406CI-TRIAL-00066794completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A before and after trial comparing the systematic use of blood salvage therapy with leucocyte filter during oncologic liver resections. Recurrence, survival, allogenic transfusion rates and surgical outcomes are compared with a representative historic cohort.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Neoplasms | Liver Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood salvage therapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- With blood salvage
- description
- Patients undergoing oncologic liver surgery with systematic use of blood salvage therapy
- interventionNames
- Procedure: Blood salvage therapy
- label
- Without blood salvage
- description
- Patients undergoing oncologic liver surgery without any blood salvage therapy
Primary outcomes (3)
- measure
- Recurrence free survival
- timeFrame
- 18 months
- measure
- Overall survival
- timeFrame
- 18 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Adult Oncologic liver surgery scheduled in our institution Exclusion Criteria: * Condition precluding consent for trial Pregnancy
References
Publications (1)
- DERIVEDLugassy L, Marion S, Balthazar F, Cheng Oviedo SG, Collin Y. Impact of blood salvage therapy during oncologic liver surgeries on allogenic transfusion events, survival, and recurrence: an ambidirectional cohort study. Int J Surg. 2024 Jun 1;110(6):3392-3400. doi: 10.1097/JS9.0000000000001458. PMID 38666789